Myriad Genetics, Inc. (MYGN)
4.18
-0.11
(-2.56%)
USD |
NASDAQ |
Feb 23, 12:18
Myriad Genetics Market Cap : 389.63M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ICU Medical, Inc. | 3.779B |
| Intuitive Surgical, Inc. | 173.95B |
| Insulet Corp. | 17.32B |
| West Pharmaceutical Services, Inc. | 17.48B |
| Celldex Therapeutics, Inc. | 1.587B |
Market Cap Related Metrics
| PS Ratio | 0.4661 |
| PEG Ratio | -0.0041 |
| Price to Book Value | 1.045 |
| Price | 4.18 |
| Earnings Yield | -103.7% |
| PEGY Ratio | -0.0041 |